Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Burn Care Res ; 29(4): 574-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18535481

RESUMO

Methamphetamine (MA) is a highly addictive drug that is easily manufactured from everyday household products and chemicals found at local farm stores. The proliferation of small MA labs has led to a dramatic increase in patients sustaining thermal injury while making and/or using MA. We hypothesized that these patients have larger injuries with longer hospital stays, and larger, nonreimbursed hospital bills compared with burn patients not manufacturing or using MA. In a retrospective case-control study, all burn patients >or=16 years of age admitted to our burn center from January 2002 to December 2005 were stratified into two groups based on urine MA status. Of the 660 burn patients >or=16 years of age admitted during this 4 year period, urine drug screens were obtained at admission on 410 patients (62%); 10% of urine drug screens were MA (+). MA (+) patients have larger burns compared with MA (-) patients (9.3 vs 8.6% body surface area burns), have higher rates of inhalation injuries (20.4 vs 9.3%, P = .015), and more nonthermal trauma (13.0 vs 3.1%, P = .001). When compared with MA (-) patients, MA (+) patients require longer hospital stays (median 9.5 vs 7.0 days, P = .036), accrue greater hospital bills per day (dollars 4292 vs dollars 2797, P = .01), and lack medical insurance (66.7 vs 17.7%, P < .0001). The epidemic of MA use and its manufacture mandates that burn centers monitor patients for MA use and develop and institute protocols to ensure proper care of this increasingly costly population.


Assuntos
Queimaduras Químicas/epidemiologia , Estimulantes do Sistema Nervoso Central/efeitos adversos , Crime , Drogas Ilícitas/efeitos adversos , Metanfetamina/efeitos adversos , Acidentes de Trânsito , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Unidades de Queimados , Queimaduras Químicas/patologia , Estudos de Casos e Controles , Estimulantes do Sistema Nervoso Central/urina , Explosões , Custos Hospitalares , Humanos , Drogas Ilícitas/urina , Escala de Gravidade do Ferimento , Seguro Saúde/estatística & dados numéricos , Tempo de Internação/estatística & dados numéricos , Pessoas sem Cobertura de Seguro de Saúde , Metanfetamina/urina , Pessoa de Meia-Idade , Meio-Oeste dos Estados Unidos/epidemiologia , Estudos Retrospectivos , Violência
2.
J Burn Care Res ; 29(1): 138-40, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18182911

RESUMO

Pseudoephedrine (PSE) is one of the main ingredients used to manufacture methamphetamine (MA); approximately 700 to 1000 PSE pills are necessary to "cook" a batch of MA. Steps have been taken to decrease the availability of ingredients needed to concoct MA. On May 21, 2005, the state of Iowa enacted a strict law, making PSE a Schedule V Controlled substance, restricting PSE availability, and sales. Using the same 6-month time frames in 2004 and 2005, we retrospectively compared epidemiological data on burn patients in the year before the new PSE law and again immediately after the law was enacted. Data collected between May 21 to December 31, 2004 and 2005 included sex, age, length of stay, body surface area burn, urine drug toxicity status, insurance status, and cost of hospital stay. Reports on statewide MA laboratory incidents were provided by the Office of Drug Control Policy. In 2004, Iowa ranked second in the nation for MA lab incidents, seizing an average of 120 labs per month. In 2006, Iowa ranked eighth in the nation for MA lab incidents, when only 20 labs per month were seized, an 83% decreased from the previous year. By limiting the availability of PSE, Iowa saw a marked decrease in MA laboratory-related incidents, leading to a drastic decrease in MA related burns statewide.


Assuntos
Acidentes , Queimaduras/prevenção & controle , Crime/legislação & jurisprudência , Explosões , Drogas Ilícitas/legislação & jurisprudência , Laboratórios/legislação & jurisprudência , Metanfetamina , Pseudoefedrina , Unidades de Queimados , Queimaduras/epidemiologia , Queimaduras/etiologia , Humanos , Iowa/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Estados Unidos/epidemiologia
3.
J Burn Care Res ; 28(6): 827-34, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17925652

RESUMO

The spectrum of cement-related injuries encompasses contact dermatitis, abrasions, ulcerations, chemical burns, and burns from explosions during the manufacturing process. The purpose of this study was to compile cement-related conditions seen in two burn units (1999-2005), literature case reports and series (1950-2006) and the (1989-2001) National Burn Repository (NBR). There were 3597 admissions in two Midwestern burn units, of which 12 cases (0.8%) were cement burns. They occurred in men, aged 15 to 64 years with a burn range of 0.25 to 10% TBSA, exposure time of 1 to 6 hours, treatment delay of 1 day to 2 weeks, hospitalization (2-14 days). Literature review of 109 cases indicated that cement-related injuries were predominantly seen in men, aged 26 to 45 years; with a cement-exposure time of 1.5 to 4 hours, treatment delay (1 day to 5 weeks), hospitalization (10-33 days), and healing time (2-7 weeks). There were 52,219 burn admissions in the NBR, of which 44 (0.08%) were cement-related burns; 95% were men with a mean age of 41 years, 6% TBSA cement burn and an 8-day hospital stay. The demographic characteristics of the burn units and NBR cases were similar to those in the literature. This preventable injury occurred primarily in the working age male patient and was associated with long healing times. Public awareness and enhanced manufacturer package warnings and education may decrease future cement-related injuries.


Assuntos
Queimaduras Químicas/epidemiologia , Materiais de Construção/efeitos adversos , Acidentes Domésticos/economia , Acidentes Domésticos/estatística & dados numéricos , Acidentes de Trabalho/economia , Acidentes de Trabalho/estatística & dados numéricos , Adolescente , Adulto , Unidades de Queimados , Queimaduras Químicas/economia , Queimaduras Químicas/etiologia , Queimaduras Químicas/terapia , Dermatite de Contato/epidemiologia , Dermatite de Contato/etiologia , Feminino , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Admissão do Paciente/estatística & dados numéricos , Sistema de Registros , Estados Unidos/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA